• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Naomi Kresge

Stay informed with Naomi Kresge’s coverage and analysis.

Ozempic CEO’s exit from Novo started with Teams call surprise
FinanceOzempic CEO’s exit from Novo started with Teams call surprise
By Naomi Kresge and BloombergMay 16, 2025
Roche, Zealand Pharma in $5.3 billion pact for obesity drugs
RetailRoche, Zealand Pharma in $5.3 billion pact for obesity drugs
By Paula Doenecke, Naomi Kresge and BloombergMarch 12, 2025
WHO offers early retirement to cut costs ahead of U.S. exit
HealthWHO offers early retirement to cut costs ahead of U.S. exit
By Bloomberg, Ashleigh Furlong and Naomi KresgeMarch 7, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
Novo Nordisk’s Wegovy sales jump on international rollouts
RetailNovo Nordisk’s Wegovy sales jump on international rollouts
By Naomi Kresge and BloombergNovember 6, 2024
A person holds up a box of Ozempic.
HealthOzempic may help manage opioid addiction: study
By Naomi Kresge and BloombergSeptember 25, 2024
Sen. Bernie Sanders is seen pointing and speaking at the opening of a Senate committee hearing.
PoliticsBernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By Madison Muller, Naomi Kresge, Riley Griffin and BloombergSeptember 24, 2024
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
HealthRoche stock is falling after report its Wegovy challenger is causing patients to vomit
By Naomi Kresge and BloombergSeptember 12, 2024
Thomas Schinecker, CEO of Roche Holding.
RetailAn obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
By Naomi Kresge, Lisa Pham and BloombergJuly 23, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk.
HealthA rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
By Naomi Kresge and BloombergJune 27, 2024
EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
HealthEU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
By Naomi Kresge and BloombergJune 26, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk.
HealthNovo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
By Naomi Kresge and BloombergJune 25, 2024
Timotheus Höttges, CEO of Deutsche Telekom.
FinanceGermany just offloaded $2.7 billion in one of its largest companies so it can bolster its railway networks
By Swetha Gopinath, Naomi Kresge and BloombergJune 4, 2024
Plumes of smoke are seen after a fire broke out at an office building belonging to Danish pharmaceutical group Novo Nordisk in Bagsvaerd near Copenhagen, Denmark, on May 22, 2024.
RetailDanish pharma giant Novo Nordisk’s office building is in danger of collapsing after a ‘massive fire’ broke out
By Sanne Wass, Naomi Kresge and BloombergMay 23, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
RetailDenmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Economy
While Trump insisted the Iran war would end ‘soon,’ an account in his name was buying millions in oil, defense, and goldplaceholder alt text
By Eva RoytburgMay 18, 2026
Politics
The Bezos family just donated $100 million to help achieve one of Mayor Zohran Mamdani’s top campaign promisesplaceholder alt text
By Jake AngeloMay 12, 2026
Personal Finance
Current price of oil as of May 18, 2026placeholder alt text
By Joseph HostetlerMay 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.